IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
Insight Molecular Diagnostics Chief Science Officer Dr. Ekkehard Schuetz has published his 200th scientific article, achieving an H-index of 58 which places him in the top 2.5% of researchers globally. Dr. Schuetz is the co-inventor of the dd-cfDNA technology underlying the company's GraftAssure family of assays.
Key figures
- H index
- 58
- Citation count
- more than 11,000
- Research ranking
- top 2% of laboratory diagnostics researchers, top 2.5% of 2.6 million researchers worldwide
- Publication count
- 200
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.